HLD Flashcards
(71 cards)
Hyperlipidemia
- HDL
- serum cholesterol >200mg/dL
- HDL-Good; clean arteries
- LDL-Bad, builds plaque
- Cholesterol, made in liver, Hormones and bile acid formation vital in neurological function
HLD Causes
-Lifestyle Choices:
- poor diet
- lack of exercise
- smoking, stress
- obesity
- diabetes (more triglycerides= lower HDL)
- Secondary: Medications (
HLD Causes
-Secondary:
- Medications: antipsychotics (risperdone), prednisone, diuretics, beta blockers (mild)
- Hypothyroidism (check thyroid)
- Primary: Genetics: Familial Hypercholesteremia
Atherosclerosis
- from untreated HLD
- build up of plaque
- increases risk of: MI, CVA, PVD, CHF, CAD
- Testing: fasting total cholest; HDL, LDL, and triglycerides. (Just total cholesterol ok for screen, but not a lot of info)
Arteriosclerosis
-hardening of the arteries
HLD Guidelines
- LDL=Less than 130
- HDL-
- ——-Men=Greater than 60
- ——-Women= Greater than 50
- Triglycerides=less than 200
- Ignore old guidelines
Start HLD Treatment
- 1st Lifestyle Changes :
- Diet=less salt, less sat fats, increase fiber, heart healthy foods
- Exercise=reg 3-4/wk, healthy weight, (exercise increases HDL, lowers LDL and triglycerides)
- less smoking and ETOH!
HLD Treatment
Risk Factors
- age
- fam hx
- smoking
- systolic bp
- total cholesterol
- HDL
- diabetes
- Assess w/ Farmingham Scale (only good for pts 20 and older)
HLD Treatment
- high risk or very high risk?
- LDL goal for high risk is
HLD MED START
- diabetes
- CAD
- hereditary
HLD Meds
- HMG-CoA Reductase Inhibitors
- Azetidinones, Ezetimibe (Zetia)
- Bile Acid Resins
- Niacin (Nictinic Acid)
- Fibric Acid Derivatives (gemfibrozil, fenofibrate)
-HMG-CoA Reductase Inhibitors
- HLD
- Simvastatin, Atorvastatin, Pravastatin
- SAFE IN Heterozygous familial hypercholesteremia
- By Inhibiting this enzyme LDL production is decreased and more LDL is catabolized, DECREASING LDLs
- Myopathy(Muscle aches)
- Arthraglia
- Diarrhea
- Increased LFTs
- MONITOR: LFTs, lipids, (CPK-with interacting drug combination, can cause myalgia)=if CPK bad try another STATIN
- ALWAYS get a BASELINE LFT and perform a 4-6 week FOLLOW UP VISIT
- If patient is on other medications:
- —-Inducers – increase statin dose
- —-Inhibitors – decrease statin dose
- NOT SAFE in PREGNANCY, BREASTFEEDING.
- SAFE in pediatrics >10 y.o.
- INSTRUCT to take with evening meal or at bedtime (more effective and DECREASES A.E.)
-HMG-CoA Reductase Inhibitors
-Simvastatin, Atorvastatin, Pravastatin
MOA
-By Inhibiting this enzyme LDL production is decreased and more LDL is catabolized, DECREASING LDLs
-HMG-CoA Reductase Inhibitors
-Simvastatin, Atorvastatin, Pravastatin
PHARM
- Not well absorbed (14%)
- Metabolized in liver via CYP3A4 (not pravatstatin)
- Excreted in bile
- Genotypes can increase risk of toxicity, increase bioavailability
-HMG-CoA Reductase Inhibitors
-Simvastatin, Atorvastatin, Pravastatin
CONTRA
- Severe hepatic disease
- Persistent elevation of LFTs
-HMG-CoA Reductase Inhibitors
-Simvastatin, Atorvastatin, Pravastatin
SE
- Myopathy (muscle aches)
- Arthraglia
- Diarrhea
- Increased LFTs
- MONITOR: LFTs, lipids, (CPK-with interacting drug combination, can cause myalgia)
-HMG-CoA Reductase Inhibitors
-Simvastatin, Atorvastatin, Pravastatin
PTS
- SAFE IN Heterozygous familial hypercholesteremia
- ALWAYS get a BASELINE LFT and perform a 4-6 week FOLLOW UP VISIT
- MONITOR: LFTs, lipids, (CPK-with interacting drug combination, can cause myalgia)=if CPK bad try another STATIN
- If patient is on other medications:
- —-Inducers – increase statin dose
- —-Inhibitors – decrease statin dose
- NOT SAFE in PREGNANCY, BREASTFEEDING.
- SAFE in pediatrics >10 y.o.
- INSTRUCT to take with evening meal or at bedtime (more effective and DECREASES A.E.)
STATIN Drug Interactions
- metabolized through CYP3A4
- Inducers=will reduce plasma concentration=increase dose of statin
- Inhibitors=will increase concentration=decrease dose of statin
Azetidinones
- HLD
- Ezetimibe (Zetia)
- INHIBITS sterol transporter at brush border to cause decrease in intestinal absorption
- DECREASES cholesterol deposition in liver and cholesterol stores
- Has NO food effect.
- INCREASED LFTS (esp if given additionally with reductase inhibitors)
- MONITOR LFTs (carefully), lipids
- UNEXPLAINED LFTs
- GOOD to combine with statins, BUT!! MONITOR EFFECTS IF PLACING WITH A STATIN
- AVOID in breastmilk
- PREG C
- used in combo w/ STATIN
Azetidinones
-Ezetimibe (Zetia)
MOA
- INHIBITS sterol transporter at brush border to cause decrease in intestinal absorption
- DECREASES cholesterol deposition in liver and cholesterol stores
- in combo w/ statin
Azetidinones
-Ezetimibe (Zetia)
PHARM
- Has NO food effect.
- Variable absorption
- 90% Protein Bound
- Metabolized primarily via glucuronide conjucation, also liver
- Excreted in stool
Azetidinones
-Ezetimibe (Zetia)
SE
- Arthralgia
- Diarrhea
- Fatigue
- INCREASED LFTS (esp if given additionally with reductase inhibitors)
- MONITOR LFTs, lipids
Azetidinones
-Ezetimibe (Zetia)
CONTRA
- Severe lipid disease
- UNEXPLAINED LFTs
Azetidinones
-Ezetimibe (Zetia)
PTS
- GOOD to combine with statins, BUT!! MONITOR EFFECTS IF PLACING WITH A STATIN
- Pregnancy: Cat C
- AVOID in breastmilk
- Safe in pediatrics >10 y.o.